Animal use reporting: 2019-2022, Waeterloos, Geneviève, and Ribaucour F , Annual OMCL meeting 2024, Common OCABR vaccine session, 2024/05/17, Issue EDQM, Ohrid, North Macedonia, (2024)

Annual use reporting: overview 2019-2022, Waeterloos, Geneviève, and Ribaucour F , OCABR Advisory group meeting, 2024-03-20, Issue EDQM, Strasbourg, France, (2024)

Best practices for lot release of mRNA vaccines, Waeterloos, Geneviève, Desmet N., and Stradiot L. , WHO-Network of National control laboratories for Biologicals- 6th Workshop, 2024/10/28, Cairo, Egypt, (2024)

DTaP Potency testing: 3R's status, Waeterloos, Geneviève, Ribaucour F, Florens Morgane, and Vermeulen M. , 6th WHO-NNB Workshop, 2024/11/27, Issue WHO, Cairo, Egypt, (2024)

EU Annual report : batch release of human vaccines, Waeterloos, Geneviève, Van Molle Wim, Tesolin L., Ribaucour F, Florens Morgane, Masquelier F., Clouet S., Domicent C., Auquier J., Laurent F., et al. , 01/04/2024, Brussels, Belgium, p.261, (2024)

EU batch release procedure: annual report 2023 - batch release of blood derivatives, Waeterloos, Geneviève, Cuignet L., and Lamme Julien , 2024/04/19, 2024/04/19, p.20, (2024)

EU Batch Release Procedure: Annual Report 2023 - Batch Release of IVMPs, Levi, S., Delferrière A., Vermeulen M., and Waeterloos Geneviève , 2024, Strasbourg, France, p.15, (2024)

Production et accès aux produits médicaux (Vaccin): Témoignage Sciensano: renforcement  (RFDA), Waeterloos, Geneviève , Evénement bi-annuel de networking:  La valeur ajoutée de l?expertise publique belge pour la coopération internationale, 2024/09/02, Issue ENABEL, Brussels, Belgium, (2024)

3R Reporting Overview, Waeterloos, Geneviève, and Ribaucour F , Annual OMCL meeting, Common OCABR session, 2023 06 09, Issue EDQM -Spanish OMCL, Madrid, Spain, (2023)

3Rs approach in the Belgian OMCL, Waeterloos, Geneviève , WHO-Network of National control laboratories for Biologicals- 5th Workshop, 2023 12 14, Issue WHO, Bangkok, Thailand, (2023)

Animal use reporting 2019 - 2022, Waeterloos, Geneviève, and Ribaucour F , OCABR Advisory group meeting, 2023 10 25, Issue EDQM, Strasbourg, France, (2023)

Batch release procedure & Activities of the service Quality of vaccines and blood products, Waeterloos, Geneviève , RFDA study visit, 2023 07 24-25, Issue Sciensano, Brussels, Belgium, (2023)

Best Practices: Out of Specification Results, Waeterloos, Geneviève , WHO-Network of National control laboratories for Biologicals- 5th Workshop, 2023 12 13-15, Issue WHO, Bangkok, Thailand, (2023)

Contrôle analytique des vaccins, Waeterloos, Geneviève , Journée thématique: contrôle qualité des produits biologiques, 2023 10 29, Issue Institut Pasteur d'Algérie, Alger, Algérie, (2023)

EU batch release procedure: Annual Report 2 - Batch Release of  Vaccines, Waeterloos, Geneviève, Auquier J., Domicent C., Cuignet L., Clouet S., Desmet N., Florens Morgane, Laurent F., Masquelier F., Ribaucour F, et al. , 2023 05 25, p.314, (2023)

EU Batch Release Procedure : Annual Report 2022 - Batch Release of Blood Derivatives, Cuignet, L., Lamme Julien, and Waeterloos Geneviève , 2023 05 25, Brussels, Belgium, p.25, (2023)

EU Batch Release Procedure: Annual Report 2022 - Batch Release of IVMPs, Levi, S., Delferrière A., Vermeulen M., and Waeterloos Geneviève , 26/05/2023, Strasbourg, France, p.14, (2023)

EU Batch Release Procedure : Annual Report 2022 - Batch Release of IVMP, Delferrière, A., Levy S., and Waeterloos Geneviève , 2023 05 26, Brussels, Belgium, p.14, (2023)

Good Practices for Batch Release, Waeterloos, Geneviève , EDQM - Vaccine manufacturers meeting, 2023 03 30, Issue EDQM, Strasbourg, France, (2023)

In vivo assays for independent batch release activities, Waeterloos, Geneviève , PARERE meeting, 2023 12 21, Issue Sciensano, Belgium, (2023)

Replacement, Reduction and Refinement (3Rs): Network Strategies, Waeterloos, Geneviève, and Florens Morgane , EU batch release for Human Vaccines: A practical overview for newcomers to the system, 2023 11 9-10, Issue EDQM, Strasbourg, France, (2023)

Review of animal reporting tables 2019 - 2021, Waeterloos, Geneviève, and Ribaucour F , OCABR Advisory group meeting, 2023 03 29, Issue EDQM, Strasbourg, France, (2023)

Training programme for vaccine lot release, Waeterloos, Geneviève , Training of National Control Laboratory of Singapour, 2023 07 11-15, Issue Health Sciences Authority, Singapour, Singapour, Singapour, (2023)

Validation of an animal-free analytical method for the detection of bacterial endotoxins in human vaccines , Laurent, Flore , 2023, VUB - Symposium 3R, (2023)

Viewpoint or an EU OMCL on OCABR and Batch Release fro outside the EU, Waeterloos, Geneviève , EU batch release for Human Vaccines: A practical overview for newcomers to the system, 2023 11 9-10, Issue EDQM, Strasbourg, France, (2023)

Auditors experience with remote audits:Preparatory phase, Waeterloos, Geneviève, Tesolin L., and Van Molle Wim , OMCL annual meeting 2022, 14/06/2022, EDQM, strasbourg, (2022)

EU Batch Release Procedure: Annual Report 2021 - Batch Release of IVMPs, Levi, S., Delferrière A., and Waeterloos Geneviève , 10/06/2022, Strasbourg, France, p.14, (2022)

Module 2: développement et production d'un vaccin  - chapitre 3: contrôle de qualité , Waeterloos, Geneviève , 2022 03, https://www.ulb.be/fr/programme/fc-742, (2022)

National perspectives on non-animal approaches for quality control and batch release testing of biologicals and the influence of WHO guidelines, Waeterloos, Geneviève, Florens Morgane, and Ribaucour F , https://www.nc3rs.org.uk/events/nc3rs-workshop-implementing-3rs-who-guidelines-understanding-impact-quality-control-and , 2022 03 02, Virtual conference, London, United Kingdom , (2022)

Panel discussion on the adoption of 3Rs and non-animal approaches for quality control and batch release testing of these products, Waeterloos, Geneviève , https://www.nc3rs.org.uk/events/nc3rs-workshop-implementing-3rs-who-guidelines-understanding-impact-quality-control-and , 2022 03 02, Virtual conference, London, United Kingdom , (2022)

EU Batch Release Procedure: Annual Report 2020 - Batch Release of IVMPs, Levi, S., Delferrière A., and Waeterloos Geneviève , 19/04/2021, Strasbourg, France, p.14, (2021)

How to implement trend analysis, Tesolin, L., Waeterloos Geneviève, Stradiot L., Ribaucour F, Auquier J., and Cuignet L. , Training Saudi Food and Drug Authority, (2021)

OCABR of Covid vaccines, a success story, Waeterloos, Geneviève, and Milne Catherine , Annual OMCL meeting _ General session, 08/09/2021, Issue EDQM, (2021)

Establishment of single dilution assays for animal based potency determinations, Waeterloos, Geneviève, Tesolin L., Ribaucour F, and Delbrassinne Laurence , WHO Webinar: Establishment of a single dilution potency assay, (2020)

EU Batch Release Procedure: Annual Report 2019 - Batch Release of IVMPs, Levi, S., Gisbert Algaba I., Grognet P., and Waeterloos Geneviève , 29/04/2020, Strasbourg, France, p.14, (2020)

Batch release of vaccines in Europe: from method transfer to first commercial batch available on the market. Straightforward approach that requires a proactive mindset of the manufacturer., Van Molle, Wim , EDQM & European Pharmacopoeia: State-of-the-Art Science for Tomorrow?s Medicines, 19-20 May 2019, Issue EDQM, (2019)

EU Batch Release Procedure: Annual Report 2018 - Batch Release of IVMPs, Gisbert Algaba, I., Grognet P., Levi S., and Waeterloos Geneviève , 25/04/2019, Strasbourg, France, p.14, (2019)

Estimating the Reliability of Low-Abundant Signals and Limited Replicate Measurements through MS2 Peak Area in SWATH, Limonier, Franck , PROTEOMICS, Nov-02-2018, (2018)

An application of mass spectrometry for quality control of biologicals: Highly sensitive profiling of plasma residuals in human plasma-derived immunoglobulin., Limonier, Franck, Van Steendam Katleen, Waeterloos Geneviève, Brusselmans Koen, Sneyers Myriam, and Deforce Dieter , J Proteomics, 2017 Jan 30, Volume 152, p.312-320, (2017)

Belgium, a WHO contracted laboratorium, Waeterloos, Geneviève , Global network of national vaccine control lab, WHO Workshop, 29/8/2016, Issue WHO, NA, (2016)

OMCL's role in OOS evaluation and communication with partners (network, MAH and beyond) and tools available, Waeterloos, Geneviève , OMCL Annual Meeting 2016, 27/5/2016, Issue European Directorate for the Quality of Medicines & HealthCare (EDQM),Council of Europe, NA, (2016)

Tetravac/Pentavac vaccines: follow-up on the aP immunogenicity assay situation, Domicent, C., Lejeune M., Stygelbout V., Brusselmans Koen, and Waeterloos Geneviève , OMCL ANNUAL MEETING 2016, 26/5/2016, Issue European Directorate for the Quality of Medicines & HealthCare (EDQM),Council of Europe, NA, (2016)

Accelerated development of vaccine benefit-risk collaboration in Europe, van der Aa, Lieke Maria, Mahy Patrick, Lernout Tinne, and Waeterloos Geneviève , Annual OMCL meeting, 0/6/2015, Issue EDQM, NA, (2015)

Batch release of vaccines in Europe: from method transfer to first commercial batch available on the market. Straightforward approach that requires a proactive mind-set of the manufacturer., Van Molle, Wim, Tesolin L., Brusselmans Koen, and Waeterloos Geneviève , PDA Europe Conference Vaccines. Featuring WHO on Challenges in Vaccines Supply to Developing Countries, 0/11/2015, Issue PDA Europe, Berlin, Germany, (2015)

Het Wetenschappelijk Instituut Volksgezondheid (WIV-ISP) organiseert de 20e bijeenkomst van het Europese netwerk van de Official Medicines Control Laboratories (OMCL), Waeterloos, Geneviève , 06/2015, Brussels, Belgium, (2015)

Impact on the Immmunogenicity and Safety of Tetanus Toxoid Vaccine in Controlled Temperature Chain and Standard Cold chain (WHO/Epicentre project), Waeterloos, Geneviève , Quality control and batch release of vaccines and blood products in Europe, 0/0/2015, Issue WIV-ISP, (2015)

Le WIV-ISP organise la 20ème assemblée du réseau européen des Laboratoires Officiels de Contrôle des Médicaments (OMCL), Waeterloos, Geneviève , 0/6/2015, Brussel, Belgium, (2015)

The Quality Control of Plasma-Derived Medicinal Products, Carabin, O., and Waeterloos Geneviève , Quality control and batch release of vaccines and blood products in Europe, 0/0/2015, Issue WIV-ISP, NA, (2015)

Semaine de la vaccination, Waeterloos, Geneviève , 0/4/2015, Brussels, Belgium, (2015)

Semaine mondiale de la vaccination 2015 : combler les lacunes en matière de vaccination, Waeterloos, Geneviève , 0/4/2015, Brussel, Belgium, (2015)

Validation of a new reference lot for the serology of an acellular pertussis vaccine, Stygelbout, V., Dobly Alexandre, Domicent C., Dubois E., Ribaucour F, and Waeterloos Geneviève , EUpert  Strain/Genomics, 0/0/2015, Issue Universitair Ziekenhuis Brussel,  WIV-ISP, (2015)

Wereldwijde vaccinatieweek 2015: de vaccinatiekloof dichten, Waeterloos, Geneviève , 0/4/2015, Brussels, Belgium, (2015)

The implementation of batch release for Hexacima/Hexyon/Hexaxim, Waeterloos, Geneviève , Annual OMCL meeting, 0/0/2014, Issue EDQM, NA, (2014)

Les vaccins : contrôles approfondis, Dobly, Alexandre, Brusselmans Koen, Tesolin L., and Waeterloos Geneviève , Vaxinfo, 3/9/2014, Volume 69, Number 10, p.7 - 10, (2014)

 Mass spectrometry-based proteomics for the quality control of intravenous immunoglobulin: Detection of possible thrombogenic impurities, Limonier, Franck, Van Steendam K., Waeterloos Geneviève, Sneyers Myriam, and Deforce D. , 13th Human ProteomeOrgonization world congres:  The proteome quest to understand biology and disease, 5/10/2014, Issue Human proteome organization, (2014)

The role of the European OMCL  network in the polio eradication programm : the example of the Belgian OMCL5114, Janssen, M, and Waeterloos Geneviève , Translational and Regulatory Science of Polio Vaccines and Antivirals" worshop, 0/0/2014, Issue NIH, NA, (2014)

Veiligheid vaccins  - Verregaande controle, Dobly, Alexandre, Brusselmans Koen, Tesolin L., and Waeterloos Geneviève , Vaxinfo, 3/9/2014, Volume 69, Number 10, p.7 - 10, (2014)

European accreditation bodies require the OMCL participation in proficiency studies independently of the performance of blind testing: a trend or a reality, Waeterloos, Geneviève, and Van Molle Wim , Annual OMCL meeting, 12/6/2013, Issue EDQM, NA, (2013)

Regulatory issues regarding manufacture and control of vaccine adjuvants. The EU situation., Van Molle, Wim, Brusselmans Koen, Tesolin L., and Waeterloos Geneviève , Modern Vaccines/adjuvants Formulation: Impact On Future Development, 17/5/2013, Issue Herriot,J.,  Vanden Bossche,G., Lausanne, Switserland, (2013)

Release testing by manufacturers & Ph.Eur. compliance: lessons learnt for competent authorities. A case study: the Extractable Volume, Van Molle, Wim, and Waeterloos Geneviève , Annual OMCL meeting, 13/6/2012, Issue EDQM, NA, (2012)

Assessing the potency of oral polio vaccine kept outside of the cold chain during a national immunization campaign in Chad, Zipursky, S., Boualam L., Cheikh D.O., Fournier-Caruana J., Hamid D., Janssen M, Kartoglu U., Waeterloos Geneviève, and Ronveaux O. , Vaccine, 5/8/2011, Volume 29, Issue 34, Number 5656, p.5652 - 5656, (2011)

Kwaliteitscontrole van biologische geneesmiddelen bij WIV-ISP3237, Waeterloos, Geneviève , Healthcare Executive, 0/0/2011, Volume 59, Number 3, p.1 - 3, (2011)

Le contrôle de qualité des médicaments biologiques au WIV-ISP2849, Waeterloos, Geneviève , Focus diagnostica, 0/4/2011, Volume 19, Issue 2, Number 39, p.37 - 39, (2011)

Le contrôle de qualité des médicaments biologiques au WIV-ISP2850, Waeterloos, Geneviève , Healthcare Executive, 0/6/2011, Volume 59, Number 3, p.1 - 3, (2011)

Implementation over the past 20 years of the 3R's principle for batch release at the Scientific Institute of Public Health, Belgium (IPH)., Van Molle, Wim, Maes A., Ribaucour F, and Waeterloos Geneviève , Quality of medicines in a globalised world: dreams and reality, 15/10/2010, Issue European Directorate for the Quality of Medicines & HealthCare (EDQM),Council of Europe, Number 99, Prague, Czech Republic, p.98 - 99, (2010)

Le contrôle de qualité des médicaments biologiques au WIV-ISP2848, Waeterloos, Geneviève , Médi-sphère, 0/12/2010, Volume 365, Number 21, p.19 - 21, (2010)

Establishment of the Ph. Eur. BRP for varicella vaccine batch 1., Akkermans, A M., Waeterloos Geneviève, Kemiha K, Daas A, and Milne C , Pharmeur Bio Sci Notes, 2009 Oct, Volume 2009, Issue 1, (2009)

Establishment of the Ph. Eur. BRP for Varicella Vaccine Batch 1227, Akkermans, A., Waeterloos Geneviève, Kemiha K., Daas A., and Milne C. , Pharmeur.Bio Sci.Notes, 0/10/2009, Volume 2009-1, Number 54, p.45 - 54, (2009)

Biological standardisation in Vaccines quality control, Waeterloos, Geneviève , Characterization and Quality of Vaccines, 2/12/2008, Issue Van Bressem,M.F., (2008)

Animal cell cultures: Risk Assessment and biosafety recommendations, Pauwels, Katia, Van Vaerenbergh Bernadette, Do Thi Chuong Dai, Berghmans L., Waeterloos Geneviève, Van Bockstaele D., Dorsch-Hasler K., and Sneyers Myriam , Appl.Biosaf., 0/0/2007, Volume 12, Issue 1, Number 38, p.26 - 38, (2007)

Animal use reporting: 2019-2023, Waeterloos, Geneviève, and Ribaucour F , OCABR Advisory group meeting, 2024/10/25, Issue EDQM, Strasbourg, France, (0)

WHO-National control Laboratories network activities, Waeterloos, Geneviève , (0)